bacille Calmette-Guérin (BCG), a vaccine for TB disease that is used in many countries but rarely used in the United States; may cause a false-positive reaction to the tuberculin skin test
a vaccine for TB named after the French scientists Calmette and Guérin BCG is not widely used in the United States, but it is often given to infants and small children in other countries where TB is common
A substance that activates the immune system Filling the bladder with a solution of BCG is a form of biological therapy for superficial bladder cancer
Bacille Calmette Guerin attenuated strain of Mycobacterium bovis used in the preparation of BCG vaccine that is used for immunization against tuberculosis and in the cancer chemotherapy Named after three scientists whose names were adopted as BCG
"Bacille Calmette Guerin" - a changed strain of M bovis developed by the Drs Calmette and Guerin in the early part of this century, repeatedly sub-cultured until it became non-virulent Used since the 1920s as a vaccine to protect against human tuberculosis
Bacille Calmette-Guerin Vaccination for TB Named after the scientists who developed the weakened strain of TB
Bacille Calmette-Guérin (BCG) is a vaccine against tuberculosis that is prepared from a strain of the attenuated (weakened) live bovine tuberculosis bacillus, Mycobacterium bovis, that has lost its virulence in humans by being specially cultured in an artificial medium for years. The bacilli have retained enough strong antigenicity to become a somewhat effective vaccine for the prevention of human tuberculosis. At best, the BCG vaccine is 80 ffective in preventing tuberculosis for a duration of 15 years, however, its protective effect appears to vary according to geography